186 related articles for article (PubMed ID: 2447318)
1. Loss of Lewis antigen expression on erythrocytes in some cancer patients with high serum CA19-9 levels.
Hirano K; Kawa S; Oguchi H; Kobayashi T; Yonekura H; Ogata H; Homma T
J Natl Cancer Inst; 1987 Dec; 79(6):1261-8. PubMed ID: 2447318
[TBL] [Abstract][Full Text] [Related]
2. Critical increment of Lewis blood group antigen in serum by cancer found by photothermal immunoassay.
Kimura H; Kitamori T; Sawada T
Anal Biochem; 1999 Oct; 274(1):98-103. PubMed ID: 10527501
[TBL] [Abstract][Full Text] [Related]
3. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer.
Tempero MA; Uchida E; Takasaki H; Burnett DA; Steplewski Z; Pour PM
Cancer Res; 1987 Oct; 47(20):5501-3. PubMed ID: 3308077
[TBL] [Abstract][Full Text] [Related]
4. Lewis and secretor gene dosages affect CA19-9 and DU-PAN-2 serum levels in normal individuals and colorectal cancer patients.
Narimatsu H; Iwasaki H; Nakayama F; Ikehara Y; Kudo T; Nishihara S; Sugano K; Okura H; Fujita S; Hirohashi S
Cancer Res; 1998 Feb; 58(3):512-8. PubMed ID: 9458099
[TBL] [Abstract][Full Text] [Related]
5. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients.
Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S
Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823
[TBL] [Abstract][Full Text] [Related]
6. Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type.
Pour PM; Tempero MM; Takasaki H; Uchida E; Takiyama Y; Burnett DA; Steplewski Z
Cancer Res; 1988 Oct; 48(19):5422-6. PubMed ID: 3166398
[TBL] [Abstract][Full Text] [Related]
7. High serum levels of DUPAN2 antigen and CA19-9 in pancreatic cancer: correlation with immunocytochemical localization of antigens in cancer cells.
Suzuki Y; Ichihara T; Nakao A; Sakamoto J; Takagi H; Nagura H
Hepatogastroenterology; 1988 Jun; 35(3):128-35. PubMed ID: 3042577
[TBL] [Abstract][Full Text] [Related]
8. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
9. Identification of an H antigen-like blood group antigen in sera of cancer patients using a novel monoclonal antibody raised against endometrial carcinoma.
Tsuji Y; Yoshioka M; Ogasawara T; Takemura T; Isojima S
Cancer Res; 1987 Jul; 47(13):3543-50. PubMed ID: 2438039
[TBL] [Abstract][Full Text] [Related]
10. Investigation of unexpected serum CA19-9 elevation in Lewis-negative cancer patients.
Hamada E; Taniguchi T; Baba S; Maekawa M
Ann Clin Biochem; 2012 May; 49(Pt 3):266-72. PubMed ID: 22492877
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine.
Kannagi R; Fukushi Y; Tachikawa T; Noda A; Shin S; Shigeta K; Hiraiwa N; Fukuda Y; Inamoto T; Hakomori S
Cancer Res; 1986 May; 46(5):2619-26. PubMed ID: 3008996
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte Lewis (A+B-) host phenotype is a factor with familial clustering for increased risk of Helicobacter pylori-related non-cardiac gastric cancer.
Sheu MJ; Yang HB; Sheu BS; Cheng HC; Lin CY; Wu JJ
J Gastroenterol Hepatol; 2006 Jun; 21(6):1054-8. PubMed ID: 16724994
[TBL] [Abstract][Full Text] [Related]
13. Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme.
Narimatsu H; Iwasaki H; Nishihara S; Kimura H; Kudo T; Yamauchi Y; Hirohashi S
Cancer Res; 1996 Jan; 56(2):330-8. PubMed ID: 8542588
[TBL] [Abstract][Full Text] [Related]
14. [Clinical investigation of carbohydrate antigen CA-50].
Ishii M; Abe O; Okura H; Okazaki N; Kawai T; Saito Y; Sawabu N; Takamizawa Y; Takeuchi T; Niitani H
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170
[TBL] [Abstract][Full Text] [Related]
15. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients.
Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM
Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196
[TBL] [Abstract][Full Text] [Related]
16. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain.
Kannagi R; Kitahara A; Itai S; Zenita K; Shigeta K; Tachikawa T; Noda A; Hirano H; Abe M; Shin S
Cancer Res; 1988 Jul; 48(13):3856-63. PubMed ID: 2454154
[TBL] [Abstract][Full Text] [Related]
17. [Serological test of carbohydrate antigen CA50 in patients with cancer of the digestive tract].
Takami H; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1987 Feb; 14(2):495-501. PubMed ID: 3468885
[TBL] [Abstract][Full Text] [Related]
18. Genetic and enzymatic evidence for Lewis enzyme expression in Lewis-negative cancer patients.
Yazawa S; Nishihara S; Iwasaki H; Asao T; Nagamachi Y; Matta KL; Narimatsu H
Cancer Res; 1995 Apr; 55(7):1473-8. PubMed ID: 7882355
[TBL] [Abstract][Full Text] [Related]
19. Comparative study on the expression of the blood group antigens Le(a), Le(b), Le(x), Le(y) and the carbohydrate antigens CA19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma.
Makovitzky J; Schwenk J
Acta Histochem Suppl; 1990; 40():143-6. PubMed ID: 2091042
[No Abstract] [Full Text] [Related]
20. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin.
Magnani JL; Steplewski Z; Koprowski H; Ginsburg V
Cancer Res; 1983 Nov; 43(11):5489-92. PubMed ID: 6193872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
